CPE Co-Authors Joint Stakeholder Statement on the First JCA Report
Joint Stakeholder Statement co-authored by CPE responding to the first Joint Clinical Assessment (JCA) report published under the EU Health Technology Assessment (HTA) Regulation.
Joint Stakeholder Statement co-authored by CPE responding to the first Joint Clinical Assessment (JCA) report published under the EU Health Technology Assessment (HTA) Regulation.
This policy paper, initiated and funded by AstraZeneca and developed in collaboration with a multidisciplinary group of academics, clinicians, patient advocates, and cancer policy… Read More
CPE White Paper on antimicrobial resistance threatening cancer care: 50% deaths linked to infections, policy recommendations for EU institutions and Member States. Read More
CPE and EFPIA Oncology Platform evaluate NCCP alignment with EBCP across 6 EU countries with policy recommendations for national and European action. Read More
CPE’s 2025 holiday message to the cancer community: gratitude, reflection on achievements, and solidarity with patients and families. Read More
Metastatic breast cancer patient Claudia shares her experience with ESR1 mutation testing and liquid biopsy: impact on treatment and access barriers. Read More
CPE Board Member Alina Comanescu’s colorectal cancer awareness video: importance of screening, early detection, and reducing cancer inequalities across Europe. Read More
Cancer Patients Europe’s 2024 year-in-review video: achievements in policy advocacy, patient surveys, EU engagement, and cancer care improvement across Europe. Read More
CPE’s EWAC 2024 webinar on smoking cessation inequalities: tobacco control policies, cessation support access, and WHO guideline adoption recommendations. Read More
CPE’s EWAC 2024 webinar on survivorship inequalities: post-treatment care, Right to Be Forgotten, mental health support, and EU policy recommendations. Read More